Genomics picking up pace in India

As the application of genomics is being realized to its full potential in both biology and applied biology, Genomics is opening up enormous avenues and ways of creating new never imagined companies and products


(Photo Courtesy of

Genomics research in India has grown leaps and bounds in the past 20 years. Funding agencies including the Department of Biotechnology (DBT), Department of Science and Technology (DST), Indian Council of Medical Research (ICMR), Council of Scientific and Industrial Research (CSIR), and Indian Council of Agricultural Research (ICAR) have been steadily increasing the quantum of funding and grant programs in the area.

Scientists from eminent institutes like IARI, CCMB, IGIB, NIPGR, and NBRI have contributed significantly towards genomics research. A good number of private, non-profit DSIR (Department of Scientific and Industrial Research) recognized institutes are gaining momentum in quality genomic research.

Currently, genomics is said to be at a very nascent stage in India. Even academic interest in this field is yet to pick-up steam.

Research data in the genomics space is minimally available in the country. Thus, in the Indian context, this calls for a collaborative effort between academia and private organizations.

At the global level, India seems to be way behind other countries. "Scientific papers published in top journals are very few, and Indian impact or even participation in global research efforts is minimal. Indian Genomic research has to improve a lot, both in quality and quantity when compared not only with western countries but also with countries like China. There needs to be a lot of transparency, reduced bureaucracy and red tapism when it comes to the process followed by funding agencies. Also, scientists need to raise the bar of grant proposals and manuscripts that are published. They need to collaborate more with the private sector. It is a surprise that India with a population of 1.2 billion is not a part of Human Genome Project, and also 1,000 Genome Project in any significant way," expressed Mr Sam Santhosh, CEO, SciGenom.


Previous 1 3 4 5 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email